Yifat Miller
Senior Academic
Co-Aggregation of Alpha-Synuclein with Amylin(HIAPP) Leads to an Increased Risk in Type ii Diabetes Patients for Developing Parkinson's Disease
Clinical studies have reported that Type II diabetes patients (T2D) are more
likely to develop Parkinson’s disease (PD). However, the mechanisms which
link these two diseases have remained elusive. In T2D, Amylin forms aggregates in the pancreas. However, it can also form neurotoxic oligomers in the brain.
likely to develop Parkinson’s disease (PD). However, the mechanisms which
link these two diseases have remained elusive. In T2D, Amylin forms aggregates in the pancreas. However, it can also form neurotoxic oligomers in the brain.
| Publication language | English |
| Pages | 524A-524A |
| Journal | Biophysical Journal |
| Volume | 108 |
| Issue number | 2 |
| Publication status | Published - 2015 |
Sustainable Development Goals
SDG 3 - Good Health and Well-being
